Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
Reisa A. Sperling(Harvard University), Michael Grundman(University of San Diego), Lawrence S. Honig(Columbia University), H. Robert Brashear(Brigham and Women's Hospital), Enchi Liu(University of Washington), Nick C. Fox(NIHR Queen Square Dementia Biomedical Research Unit), Kristen Morris(Janssen (United States)), Anton P. Porsteinsson(University of Rochester), David J. Brooks(Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas), H. Michael Arrighi(Sunesis (United States)), Murray A. Raskind(University of Washington), Gene G. Kinney(United States Military Academy), Ivan Lieberburg(Sunesis (United States)), Jerome Barakos(California Pacific Medical Center), Yuan Lü(Jazz Pharmaceuticals (United States)), Donatella Tampieri(Montreal Neurological Institute and Hospital), Marwan N. Sabbagh(Cleveland Clinic), Ronald S. Black(Pfizer (United States)), Keith M. Gregg(Janssen (United States)), Stephen Salloway(Providence College)
Cited by 510
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k